Literature DB >> 24939324

Regadenoson for myocardial perfusion imaging: Is it safe?

Fadi G Hage1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24939324     DOI： 10.1007/s12350-014-9922-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  37 in total

1.  Adenosine A2(A) receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy.

Authors:  Maria Grazia Andreassi; Franco Laghi Pasini; Eugenio Picano; Pier Leopoldo Capecchi; Gerarda Pompella; Ilenia Foffa; Andrea Borghini; Rosa Sicari
Journal:  Pharmacogenet Genomics       Date:  2011-08       Impact factor: 2.089

2.  Coronary vasospasm during a regadenoson stress test.

Authors:  Stephen J Bagley; Scott M Lilly; Andrew J Litwack
Journal:  Cardiol J       Date:  2012       Impact factor: 2.737

3.  "First do no harm" revisited.

Authors:  Daniel K Sokol
Journal:  BMJ       Date:  2013-10-25

4.  Complete heart block associated with regadenoson: a real side effect.

Authors:  Anil Pandit; Samuel Unzek Freiman
Journal:  J Nucl Cardiol       Date:  2012-08-23       Impact factor: 5.952

5.  A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.

Authors:  Fadi G Hage; Phillip Dean; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-07-22       Impact factor: 5.952

6.  Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Authors:  Manuel D Cerqueira; Patricia Nguyen; Peter Staehr; S Richard Underwood; Ami E Iskandrian
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

7.  Locations of coronary artery lesions in patients with severe conduction disturbance.

Authors:  Murat Yesil; Erdinc Arikan; Nursen Postaci; Serdar Bayata; Rustem Yilmaz
Journal:  Int Heart J       Date:  2008-09       Impact factor: 1.862

8.  Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.

Authors:  Fadi G Hage; Jaekyeong Heo; Billy Franks; Luiz Belardinelli; Brent Blackburn; Whedy Wang; Ami E Iskandrian
Journal:  Am Heart J       Date:  2009-03-06       Impact factor: 4.749

9.  Capillary supply to the sinus node in subjects with long-term atrial fibrillation.

Authors:  Aquilino Hurlé; Damián Sánchez-Quintana; Siew Y Ho; Eduardo Bernabeu; Margarita Murillo; Vicente Climent
Journal:  Ann Thorac Surg       Date:  2010-01       Impact factor: 4.330

10.  A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.

Authors:  Karthik Ananthasubramaniam; Robert Weiss; Bruce McNutt; Barbara Klauke; Kathleen Feaheny; Stan Bukofzer
Journal:  J Nucl Cardiol       Date:  2012-01-19       Impact factor: 5.952
View more
  12 in total

1.  Vasodilator stress agents for myocardial perfusion imaging.

Authors:  Rayan Saab; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-02-02       Impact factor: 5.952

2.  Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers.

Authors:  Mridula Rai; Alan W Ahlberg; Julianna Marwell; Waseem Chaudhary; John A Savino; Eric L Alter; Milena J Henzlova; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2016-02-22       Impact factor: 5.952

Review 3.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2015-04-30       Impact factor: 5.952

5.  Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2014-10       Impact factor: 5.952

6.  Effect of aminophylline administration on the diagnostic yield of vasodilator myocardial perfusion imaging.

Authors:  Hussein Abu Daya; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-06-03       Impact factor: 5.952

7.  Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015-Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2016-02-18       Impact factor: 5.952

8.  Adverse effects associated with regadenoson myocardial perfusion imaging.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

Review 9.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

10.  Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.

Authors:  Efstathia Andrikopoulou; Charity J Morgan; Lizbeth Brice; Navkaranbir S Bajaj; Harish Doppalapudi; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-10-17       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.